NCT03770143

Brief Summary

Depending on recent studies in literature the investigators aimed to compare whether gastrointestinal tolerance differs between infants fed with palm olein containing or palm olein free formulas. Besides it is showed that palm olein containing formulas decreases the absorption of fat and calcium by forming insoluble calcium soaps. So it is suggested that intestinal flora might be affected as a reason of these specialties. This study also aimed to investigate with culture-independent methods whether feeding infants with palm olein free formula results in the modification of their intestinal microbiota in such a way that is similar to breastfed ones.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2016

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2016

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

May 11, 2016

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2016

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2016

Completed
2.2 years until next milestone

First Posted

Study publicly available on registry

December 10, 2018

Completed
Last Updated

April 23, 2019

Status Verified

December 1, 2018

Enrollment Period

3 months

First QC Date

May 11, 2016

Last Update Submit

April 22, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Stool consistency

    Amsterdam Infant Stool Scale

    10 weeks

Secondary Outcomes (1)

  • Bacteria Count

    10 weeks

Study Arms (3)

Group 1

Infants feeding predominantly with palm olein free formula if presence in addition to breast milk for 8 weeks of life

Other: Feeding with palm olein formula

Group 2

Infants feeding with other formulas including palm olein if presence in addition to breast milk for 8 weeks of life

Group 3

Having similar demographical properties with infants feeding with breast milk (gender, age, weight, height)

Interventions

Eligibility Criteria

AgeUp to 3 Months
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

A total of 90 healthy infants (30 under breast-feeding, 30 feeding with palm olein free formula and 30 feeding with palm olein formula) will be included. Infants feeding enterally more than %70 with breast milk will be considered as breast-feeding. Infants who had not adequate weight gain and need formula will be randomized to receive either palm olein or palm olein free term formula in addition to mother milk. Parental informed consent will be taken and infants whose parents give permission will be included.

You may qualify if:

  • The data of the patients who fulfilled the following criteria are evaluated.
  • Term infants between 38 and 40 weeks of gestational age and/or with a birth weight of \> 2500grams who are either breastfed or formula fed.
  • Selection of the subgroup using oral nutrition
  • Feeding predominantly with palm olein free formula if presence in addition to breast milk for 8 weeks of life
  • Feeding with other formulas including palm olein if presence in addition to breast milk for 8 weeks of life Selection of the subgroup not using oral nutritional supplement (control group)
  • Having similar demographical properties with infants feeding with breast milk (gender, age, weight, height)

You may not qualify if:

  • Infants with major congenital abnormalities will be excluded.
  • Infants with lack of data will also be excluded.
  • Infants, whose parents don't agree with informed consent, will be excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kanuni Sultan Suleyman Training and Research Hospital

Istanbul, Kucukcekmece, 34303, Turkey (Türkiye)

Location

Study Officials

  • Seda Yilmaz Semerci

    Kanuni SSTRH

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor, MD,PhD

Study Record Dates

First Submitted

May 11, 2016

First Posted

December 10, 2018

Study Start

May 1, 2016

Primary Completion

August 1, 2016

Study Completion

October 1, 2016

Last Updated

April 23, 2019

Record last verified: 2018-12

Locations